tiprankstipranks
Siemens Healthineers AG (MX:SHLN)
:SHLN
Mexico Market
SHLN
Siemens Healthineers AG
RESEARCH TOOLSreports

Siemens Healthineers AG (SHLN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

SHLN Analyst Ratings

Moderate Buy
11Ratings
Moderate Buy
7 Buy
4 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Siemens
Healthineers AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SHLN Stock 12 Month Forecast

Average Price Target

$848.21
▲(23.11% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Siemens Healthineers AG in the last 3 months. The average price target is $848.21 with a high forecast of $986.29 and a low forecast of $729.86. The average price target represents a 23.11% change from the last price of $689.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"688":"$688","877":"$877","1066":"$1,066","782.5":"$782.5","971.5":"$971.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":986.290561,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$986.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":848.20988246,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$848.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":729.85501514,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$729.86</span>\n  </div></div>","useHTML":true}}],"tickPositions":[688,782.5,877,971.5,1066],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,689,711.8685046923077,734.7370093846154,757.6055140769231,780.4740187692307,803.3425234615385,826.2110281538462,849.0795328461538,871.9480375384616,894.8165422307693,917.6850469230769,940.5535516153847,963.4220563076924,{"y":986.290561,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,689,701.2469140353846,713.4938280707693,725.7407421061539,737.9876561415384,750.2345701769231,762.4814842123077,774.7283982476923,786.975312283077,799.2222263184616,811.4691403538461,823.7160543892307,835.9629684246154,{"y":848.20988246,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,689,692.1426934723077,695.2853869446154,698.4280804169231,701.5707738892307,704.7134673615385,707.8561608338462,710.9988543061538,714.1415477784615,717.2842412507692,720.4269347230769,723.5696281953846,726.7123216676923,{"y":729.85501514,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":982.459,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1013.698,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1065.754,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":866.389,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":866.389,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":898.489,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":918.93,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":795.99,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":780,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":704,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":689,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":689,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":689,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$986.29Average Price Target$848.21Lowest Price Target$729.86
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Berenberg Bank Analyst forecast on MX:SHLN
Sam England
Berenberg Bank
Berenberg Bank
$789.03
Hold
14.52%
Upside
Reiterated
09/11/26
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Lyell Immunopharma (NASDAQ: LYEL)
J.P. Morgan Analyst forecast on MX:SHLN
Anchal Verma
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
09/09/26
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (NASDAQ: IONS), Healthequity (NASDAQ: HQY) and Siemens Healthineers AG (Other OTC: SEMHF)
Jefferies Analyst forecast on MX:SHLN
Julien Dormois
Jefferies
Jefferies
$986.29
Buy
43.15%
Upside
Reiterated
09/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Citi Analyst forecast on MX:SHLN
Veronika Dubajova
Citi
Citi
$887.66→$907.39
Buy
31.70%
Upside
Reiterated
08/27/26
Siemens Healthineers price target raised to EUR 46 from EUR 45 at CitiSiemens Healthineers price target raised to EUR 46 from EUR 45 at Citi
Deutsche Bank Analyst forecast on MX:SHLN
Falko Friedrichs
Deutsche Bank
Deutsche Bank
$749.58→$769.31
Hold
11.66%
Upside
Reiterated
08/18/26
Deutsche Bank Sticks to Their Hold Rating for Siemens Healthineers AG (SEMHF)
DZ BANK AG Analyst forecast on MX:SHLN
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
―
Buy
―
Reiterated
08/07/26
RBC Capital Analyst forecast on MX:SHLN
Natalia Webster
RBC Capital
RBC Capital
$887.66
Buy
28.83%
Upside
Reiterated
08/07/26
Analysts Offer Insights on Healthcare Companies: Oxford BioMedica (Other OTC: OXBDF) and Siemens Healthineers AG (Other OTC: SEMHF)
Bernstein Analyst forecast on MX:SHLN
Susannah Ludwig
Bernstein
Bernstein
$901.47→$877.8
Buy
27.40%
Upside
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
UBS Analyst forecast on MX:SHLN
Graham Doyle
UBS
UBS
$749.58
Hold
8.79%
Upside
Reiterated
08/03/26
Siemens Healthineers AG (SEMHF) Gets a Hold from UBS
Barclays Analyst forecast on MX:SHLN
Hassan Al-Wakeel
Barclays
Barclays
$986.29→$936.98
Buy
35.99%
Upside
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Repligen (NASDAQ: RGEN)
Morgan Stanley Analyst forecast on MX:SHLN
Aisyah Noor
Morgan Stanley
Morgan Stanley
$808.76→$729.86
Hold
5.93%
Upside
Reiterated
06/23/26
Siemens Healthineers price target lowered to EUR 37 at Morgan StanleySiemens Healthineers price target lowered to EUR 37 at Morgan Stanley
Goldman Sachs Analyst forecast on MX:SHLN
Richard Felton
Goldman Sachs
Goldman Sachs
$887.66→$828.48
Hold
20.24%
Upside
Reiterated
05/11/26
Goldman Sachs Remains a Hold on Siemens Healthineers AG (SEMHF)
Kepler Capital Analyst forecast on MX:SHLN
Oliver Reinberg
Kepler Capital
Kepler Capital
$966.56→$907.39
Buy
31.70%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Sandoz Group Ltd (Other OTC: SDZXF)
DBS Analyst forecast on MX:SHLN
Nico Chen
DBS
DBS
$1,025.74
Buy
48.87%
Upside
Reiterated
02/24/26
DBS Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)
Exane BNP Paribas Analyst forecast on MX:SHLN
Unknown Analyst
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
$946.84
Hold
37.42%
Upside
Downgraded
12/10/25
Siemens Healthineers AG (SEMHF) was downgraded to a Hold Rating at Exane BNP Paribas
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Berenberg Bank Analyst forecast on MX:SHLN
Sam England
Berenberg Bank
Berenberg Bank
$789.03
Hold
14.52%
Upside
Reiterated
09/11/26
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Lyell Immunopharma (NASDAQ: LYEL)
J.P. Morgan Analyst forecast on MX:SHLN
Anchal Verma
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
09/09/26
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (NASDAQ: IONS), Healthequity (NASDAQ: HQY) and Siemens Healthineers AG (Other OTC: SEMHF)
Jefferies Analyst forecast on MX:SHLN
Julien Dormois
Jefferies
Jefferies
$986.29
Buy
43.15%
Upside
Reiterated
09/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Citi Analyst forecast on MX:SHLN
Veronika Dubajova
Citi
Citi
$887.66→$907.39
Buy
31.70%
Upside
Reiterated
08/27/26
Siemens Healthineers price target raised to EUR 46 from EUR 45 at CitiSiemens Healthineers price target raised to EUR 46 from EUR 45 at Citi
Deutsche Bank Analyst forecast on MX:SHLN
Falko Friedrichs
Deutsche Bank
Deutsche Bank
$749.58→$769.31
Hold
11.66%
Upside
Reiterated
08/18/26
Deutsche Bank Sticks to Their Hold Rating for Siemens Healthineers AG (SEMHF)
DZ BANK AG Analyst forecast on MX:SHLN
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
―
Buy
―
Reiterated
08/07/26
RBC Capital Analyst forecast on MX:SHLN
Natalia Webster
RBC Capital
RBC Capital
$887.66
Buy
28.83%
Upside
Reiterated
08/07/26
Analysts Offer Insights on Healthcare Companies: Oxford BioMedica (Other OTC: OXBDF) and Siemens Healthineers AG (Other OTC: SEMHF)
Bernstein Analyst forecast on MX:SHLN
Susannah Ludwig
Bernstein
Bernstein
$901.47→$877.8
Buy
27.40%
Upside
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
UBS Analyst forecast on MX:SHLN
Graham Doyle
UBS
UBS
$749.58
Hold
8.79%
Upside
Reiterated
08/03/26
Siemens Healthineers AG (SEMHF) Gets a Hold from UBS
Barclays Analyst forecast on MX:SHLN
Hassan Al-Wakeel
Barclays
Barclays
$986.29→$936.98
Buy
35.99%
Upside
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Repligen (NASDAQ: RGEN)
Morgan Stanley Analyst forecast on MX:SHLN
Aisyah Noor
Morgan Stanley
Morgan Stanley
$808.76→$729.86
Hold
5.93%
Upside
Reiterated
06/23/26
Siemens Healthineers price target lowered to EUR 37 at Morgan StanleySiemens Healthineers price target lowered to EUR 37 at Morgan Stanley
Goldman Sachs Analyst forecast on MX:SHLN
Richard Felton
Goldman Sachs
Goldman Sachs
$887.66→$828.48
Hold
20.24%
Upside
Reiterated
05/11/26
Goldman Sachs Remains a Hold on Siemens Healthineers AG (SEMHF)
Kepler Capital Analyst forecast on MX:SHLN
Oliver Reinberg
Kepler Capital
Kepler Capital
$966.56→$907.39
Buy
31.70%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Sandoz Group Ltd (Other OTC: SDZXF)
DBS Analyst forecast on MX:SHLN
Nico Chen
DBS
DBS
$1,025.74
Buy
48.87%
Upside
Reiterated
02/24/26
DBS Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)
Exane BNP Paribas Analyst forecast on MX:SHLN
Unknown Analyst
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
$946.84
Hold
37.42%
Upside
Downgraded
12/10/25
Siemens Healthineers AG (SEMHF) was downgraded to a Hold Rating at Exane BNP Paribas
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
HITIHigh Tide
JAZZJazz Pharmaceuticals
OMCLOmnicell
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Siemens Healthineers AG

3 Months
Oliver ReinbergKepler Capital
Success Rate
6/11 ratings generated profit
55%
Average Return
-0.49%
Copying Oliver Reinberg's trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of -0.49% per trade.
1 Year
Hassan Al-WakeelBarclays
Success Rate
13/36 ratings generated profit
36%
Average Return
-2.20%
Copying Hassan Al-Wakeel's trades and holding each position for 1 Year would result in 36.11% of your transactions generating a profit, with an average return of -2.20% per trade.
2 Years
Hassan Al-WakeelBarclays
Success Rate
13/36 ratings generated profit
36%
Average Return
-4.32%
Copying Hassan Al-Wakeel's trades and holding each position for 2 Years would result in 36.11% of your transactions generating a profit, with an average return of -4.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHLN Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
14
10
9
1
1
Buy
12
9
11
12
13
Hold
8
8
10
10
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
34
27
30
23
24
In the current month, SHLN has received 14 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. SHLN average Analyst price target in the past 3 months is 848.21.
Each month's total comprises the sum of three months' worth of ratings.

SHLN Financial Forecast

SHLN Earnings Forecast

Next quarter’s earnings estimate for SHLN is $13.58 with a range of $12.75 to $13.84. The previous quarter’s EPS was $13.84. SHLN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SHLN has Performed in-line its overall industry.
Next quarter’s earnings estimate for SHLN is $13.58 with a range of $12.75 to $13.84. The previous quarter’s EPS was $13.84. SHLN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SHLN has Performed in-line its overall industry.

SHLN Sales Forecast

Next quarter’s sales forecast for SHLN is $134.02B with a range of $130.35B to $139.78B. The previous quarter’s sales results were $113.94B. SHLN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SHLN has Performed in-line its overall industry.
Next quarter’s sales forecast for SHLN is $134.02B with a range of $130.35B to $139.78B. The previous quarter’s sales results were $113.94B. SHLN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SHLN has Performed in-line its overall industry.

SHLN Stock Forecast FAQ

What is MX:SHLN’s average 12-month price target, according to analysts?
Based on analyst ratings, Siemens Healthineers AG’s 12-month average price target is 848.21.
    What is MX:SHLN’s upside potential, based on the analysts’ average price target?
    Siemens Healthineers AG has 23.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Siemens Healthineers AG a Buy, Sell or Hold?
          Siemens Healthineers AG has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 4 hold ratings and 0 sell ratings.
            What is Siemens Healthineers AG’s share price target?
            The average share price target for Siemens Healthineers AG is 848.21. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $986.29 ,and the lowest forecast is $729.86. The average share price target represents 23.11% Increase from the current price of $689.
              What do analysts say about Siemens Healthineers AG?
              Siemens Healthineers AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of Siemens Healthineers AG?
                To buy shares of MX:SHLN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.